Investment firm Barclays laid out its thoughts for the technology space in 2025 in a research note on Thursday. Read for more ...

Discover how the S&P 500 Index performed in 2024 and what that could mean for the first quarter of 2025 according to Barclays ...

Barclays Plc’s Stephen Dainton is preparing for a wave of dealmaking this year as more US companies have been buoyed by ...

Barclays PLC BARC shares inched down 0.26% to £2.65 Wednesday, on what proved to be an all-around positive trading session ...

Emmanuel Cau, head of European equity strategy at Barclays, weighs in on the outlook for European stocks in 2025.

Barclays PLC BARC shares slid 2.60% to £2.66 Tuesday, on what proved to be an all-around grim trading session for the stock ...

Barclays started off coverage on Levi Strauss & Co. (NYSE:LEVI) with an Overweight rating on its view that organic sales ...

Barclays analyst Peter Lawson maintained a Hold rating on Blueprint Medicines (BPMC – Research Report) today and set a price target of $105.00.

In a report released today, Seth Sigman from Barclays maintained a Hold rating on Five Below (FIVE – Research Report), with a price target of ...

We recently published a list of 15 AI Stocks That Skyrocketed in Q4. In this article, we are going to take a look at where ...

Over the past two weeks, few teams have been as hot as the Detroit Pistons. Following another victory, their star player gave ...

Analysts at London-based multinational bank Barclays are speculating that Boeing’s stocks could be on the uptick to recovery ...